Applied DNA Sciences (APDN) Stock Chart & Stock Price History → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free APDN Stock Alerts $3.69 +0.09 (+2.50%) (As of 01:51 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Applied DNA Sciences Stock Price Performance5 Day Performance+2.13%1 Month Performance-51.70%3 Month Performance-68.08%6 Month Performance-79.18%Year-To-Date Performance-68.95%1 Year Performance-81.50% Receive APDN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBREAKING – Pentagon to Spend $20 Billion on “Distributed AI”BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it.Discover the name and ticker of this $2 stock here >>> APDN Stock Chart for Wednesday, May, 8, 2024 APDN Chart by TradingView Applied DNA Sciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$3.63$3.60-0.83%$3.77$3.27101,495 shs$3.06 million05/06/2024$3.75$3.63-3.20%$3.92$3.5938,829 shs$3.09 million05/03/2024$4.09$3.75-8.31%$4.75$3.59145,849 shs$3.18 million05/02/2024$4.03$4.09+1.49%$4.16$3.9415,124 shs$3.48 million05/01/2024$4.01$4.03+0.50%$4.39$3.7149,677 shs$3.43 million04/30/2024$3.85$4.01+4.16%$4.09$3.6046,175 shs$3.41 million Get the Latest News and Ratings for APDN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$4.37$3.85-11.90%$4.34$3.7036,092 shs$3.27 million04/26/2024$5.00$4.37-12.60%$4.92$4.1084,030 shs$74.20 million04/25/2024$4.78$5.00+4.69%$5.07$4.07100,712 shs$84.90 million04/24/2024$5.80$4.78-17.66%$5.60$4.4060,181 shs$4.06 million04/23/2024$6.60$5.80-12.12%$6.78$5.6040,571 shs$4.92 million04/22/2024$6.86$6.60-3.82%$7.10$6.601,769 shs$5.60 million04/19/2024$6.90$6.86-0.55%$7.40$6.604,263 shs$5.83 million04/18/2024$6.66$6.90+3.60%$7.52$6.606,510 shs$5.86 million04/17/2024$6.89$6.66-3.28%$7.40$6.304,181 shs$5.65 million04/16/2024$7.20$6.89-4.41%$7.60$6.808,831 shs$5.85 million04/15/2024$7.58$7.20-4.91%$7.80$7.206,167 shs$6.12 million04/12/2024$7.62$7.58-0.58%$7.94$7.501,850 shs$6.43 million04/11/2024$7.70$7.62-1.04%$7.96$7.605,151 shs$6.47 million04/10/2024$7.82$7.70-1.56%$8.40$7.692,343 shs$6.54 million04/09/2024$7.93$7.82-1.36%$8.60$7.694,824 shs$6.64 million04/08/2024$7.80$7.93+1.64%$8.00$7.805,244 shs$6.73 million04/05/2024$8.00$7.82-2.27%$8.40$7.803,955 shs$6.64 million04/04/2024$8.80$8.00-9.07%$8.42$7.4017,480 shs$6.79 million04/03/2024$8.58$8.80+2.56%$9.00$8.204,767 shs$7.47 million04/02/2024$8.40$8.58+2.14%$8.88$8.102,518 shs$7.28 million04/01/2024$8.20$8.40+2.44%$9.20$8.406,968 shs$7.13 million03/29/2024$8.20$8.20$8.98$8.202,525 shs$6.96 million03/28/2024$8.56$8.20-4.21%$8.98$8.202,519 shs$6.96 million03/27/2024$8.71$8.56-1.77%$8.98$8.203,129 shs$7.27 million03/26/2024$9.60$8.71-9.23%$9.80$8.714,060 shs$7.40 million03/25/2024$9.98$9.60-3.81%$9.90$9.232,899 shs$8.15 million03/22/2024$10.00$9.98-0.20%$10.13$9.404,784 shs$8.47 million03/21/2024$10.00$10.00$10.13$9.065,445 shs$8.49 million03/20/2024$8.93$10.00+11.98%$10.44$8.6010,589 shs$8.49 million03/19/2024$8.80$8.93+1.48%$9.54$8.2011,346 shs$7.58 million03/18/2024$7.36$8.80+19.57%$9.00$7.4451,485 shs$7.47 million03/15/2024$7.44$7.36-1.08%$8.60$7.3612,132 shs$6.25 million03/14/2024$9.67$7.44-23.08%$10.75$7.4423,073 shs$6.32 million03/13/2024$10.60$9.67-8.75%$11.02$9.677,098 shs$8.21 millionCould this Tiny Biotech End Disease Forever? (Ad)Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now.03/12/2024$10.60$10.60$11.76$10.604,334 shs$9.00 million03/11/2024$10.88$10.60-2.57%$11.40$10.402,504 shs$9.00 million03/08/2024$11.18$10.74-3.94%$11.00$10.357,403 shs$9.12 million03/07/2024$11.24$11.18-0.57%$11.35$11.001,779 shs$9.49 million03/06/2024$11.40$11.24-1.40%$11.40$10.825,946 shs$9.54 million03/05/2024$11.04$11.40+3.26%$11.50$10.963,183 shs$9.68 million03/04/2024$11.20$11.04-1.43%$11.60$11.004,125 shs$9.37 million03/01/2024$11.63$11.20-3.66%$12.00$11.005,456 shs$9.51 million02/29/2024$11.75$11.63-1.07%$12.38$11.402,072 shs$9.87 million02/28/2024$11.84$11.75-0.74%$12.20$11.232,414 shs$9.98 million02/27/2024$12.36$11.84-4.21%$12.46$11.805,931 shs$10.05 million02/26/2024$13.00$12.36-4.92%$13.00$11.803,944 shs$10.49 million02/23/2024$13.15$12.85-2.30%$14.34$12.227,026 shs$10.91 million02/22/2024$13.40$13.15-1.87%$13.78$12.984,196 shs$11.16 million02/21/2024$13.62$13.40-1.62%$14.40$12.9810,296 shs$11.38 million02/20/2024$12.80$13.62+6.41%$14.40$13.0016,847 shs$11.56 million02/19/2024$12.80$12.80$13.50$11.9119,085 shs$10.87 million02/16/2024$12.12$13.00+7.28%$13.50$11.9118,937 shs$11.04 million02/15/2024$12.08$12.12+0.31%$12.30$11.601,272 shs$10.29 million02/14/2024$11.80$12.08+2.37%$12.40$11.605,377 shs$10.26 million02/13/2024$11.32$11.80+4.24%$12.01$11.221,792 shs$10.02 million02/12/2024$12.20$11.32-7.21%$12.40$11.242,016 shs$9.61 million02/09/2024$12.00$12.20+1.67%$12.60$11.406,083 shs$8.39 million02/08/2024$12.00$12.00+0.02%$12.60$11.804,954 shs$8.25 million02/07/2024$11.31$12.00+6.08%$12.41$11.807,050 shs$8.25 million Related Companies: SuperCom Stock Chart Greenwave Technology Solutions Stock Chart JE Cleantech Stock Chart Crown ElectroKinetics Stock Chart American Rebel Stock Chart LogicMark Stock Chart Mobilicom Stock Chart Advent Technologies Stock Chart Digital Ally Stock Chart Multi Ways Stock Chart Receive APDN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:APDN) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied DNA Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.